Nestvold Håkon H, Skurtveit Svetlana, Hamina Aleksi, Hjellvik Vidar, Odsbu Ingvild
Norwegian Centre for Addiction Research (SERAF), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Chronic Diseases, Division of Mental and Physical Health, the Norwegian Institute of Public Health, Oslo, Norway.
Scand J Public Health. 2024 Aug 22:14034948241266744. doi: 10.1177/14034948241266744.
We aimed to investigate the association between being an immigrant and long-term prescription opioid use in Norway in 2010-2019.
Nested case-control study. The cases were all persons 18 years of age or older with long-term opioid use - that is, the use of prescription opioids longer than 3 months (=215,642). Cases were matched to four controls who filled at least one opioid prescription, but never developed long-term opioid use in the study period (=862,568) on sex, age and year of starting long-term/short-term opioid use. Being an immigrant was defined as being born outside of Norway to two foreign-born parents and four foreign-born grandparents. Adjusting for socioeconomic variables and clinical confounders, analyses were stratified on three age groups (18-44 years, 45-67 years and ⩾68 years).
For the youngest age group, being an immigrant was inversely associated with long-term opioid use (adjusted odds ratio 0.75; 95% confidence interval [0.72-0.77]) compared with being native-born people. For this age group, the odds ratio differed between people born in Africa (0.56 [0.52-0.62]), Central or South America (0.70 [0.62-0.79]), Europe outside the European Union (EU) (0.71 [0.65-0.77]), Asia including Turkey (0.80 [0.77-0.84]) and EU/European Economic Area (EEA) (0.81 [0.77-0.85]). For the middle age group, increased odds were found for immigrants versus natives (1.05 [1.02-1.08]) in particular for those born in North America (1.26 [1.13-1.40]) and the EU/EEA (1.13 [1.09-1.18]). There was no association in the oldest group.
Compared with native-born people, immigrants had lower odds of long-term opioid use among younger adults, higher odds among middle-aged and similar odds among older adults.
我们旨在调查2010 - 2019年在挪威移民身份与长期使用处方阿片类药物之间的关联。
嵌套病例对照研究。病例为所有18岁及以上长期使用阿片类药物的人,即使用处方阿片类药物超过3个月(=215,642人)。病例与四名对照进行匹配,这些对照至少开具过一次阿片类药物处方,但在研究期间从未出现长期阿片类药物使用情况(=862,568人),匹配因素包括性别、年龄以及开始长期/短期使用阿片类药物的年份。移民定义为父母双方及祖父母均出生于挪威境外。在对社会经济变量和临床混杂因素进行调整后,分析按三个年龄组(18 - 44岁、45 - 67岁和≥68岁)进行分层。
在最年轻的年龄组中,与本土出生的人相比,移民与长期使用阿片类药物呈负相关(调整后的优势比为0.75;95%置信区间[0.72 - 0.77])。对于该年龄组,出生于非洲的人(0.56 [0.52 - 0.62])、中美洲或南美洲的人(0.70 [0.62 - 0.79])、欧盟以外的欧洲地区(0.71 [0.65 - 0.77])、包括土耳其在内的亚洲地区(0.80 [0.77 - 0.84])以及欧盟/欧洲经济区(0.81 [0.77 - 0.85])的优势比有所不同。在中年年龄组中,与本土出生的人相比,移民的优势比增加(1.05 [1.02 - 1.08]),特别是出生于北美洲的人(1.26 [1.13 - 1.40])和欧盟/欧洲经济区的人(1.13 [1.09 - 1.18])。在最年长的年龄组中没有关联。
与本土出生的人相比,移民在年轻成年人中长期使用阿片类药物的几率较低,在中年成年人中几率较高,在老年成年人中几率相似。